Ratnakar Securities Pvt. Ltd.

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private

BSE1839.50-16.75 (-0.9 %)

PREV CLOSE ( ) 1856.25

OPEN PRICE ( ) 1856.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4923

TODAY'S LOW / HIGH ( )1832.45 1894.55

52 WK LOW / HIGH ( )1221 2636

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1990

Management Info

C C Paarthipan - Chairman Sridhar Ganesan - Managing Director

Registered Office

Address 3rd Floor, â€œ Ashvich Towersâ€,No.3, Developed Plots Industrial Estate,Perungudi,
Chennai,
Tamil Nadu-600096

Phone 044-24968000 / 8012772888 / 71148000

Email info@caplinpoint.net

Website www.caplinpoint.net

Registrars Details

Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai

Listing : BSE, NSE

NEWS

27Feb Caplin Pointâ€™s arm gets USFDAâ€™s fi
Caplin Point Laboratoriesâ€™ subsidiary -- Caplin Steriles has been gran..

05Feb Caplin Pointâ€™s arm gets USFDAâ€™s ap
Caplin Point Laboratoriesâ€™ subsidiary -- Caplin Steriles has been gran..

05Feb Caplin Point surges as its arm gets US
Caplin Point Laboratories is currently trading at Rs 2193.00, up by 85.7..

05Feb Caplin Point Laboratories informs abou
Caplin Point Laboratories has informed that Press Release regarding rece..

17Jan Caplin Pointâ€™s arm gets USFDAâ€™s ap
Caplin Point Laboratoriesâ€™ Subsidiary--Caplin Steriles has been grante..

Financials

in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	747.1	2837.1
Gross Profit	1001.7	3657.4
Operating Profit	1062.2	3929.2
Net Sales	1852.3	6250.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 11108.20 (1.35%)	M.Cap ( in Cr)14251.70
Hester Biosciences (BSE) 1348.95 (4.82%)	M.Cap ( in Cr)1147.53
Sanofi India (BSE) 5587.85 (0.59%)	M.Cap ( in Cr)12869.17
Mankind Pharma (BSE) 2201.10 (1.46%)	M.Cap ( in Cr)90812.66
Concord Biotech (BSE) 1648.15 (1.80%)	M.Cap ( in Cr)17242.32

Shareholding Pattern

	PROMOTERS	70.56%
	NON-INSTITUTION	22.47%
	MUTUAL FUNDS/UTI	1.86%
	FI/BANKS/INSURANCE	0.14%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Samco Flexi Cap Fun...	6.19
Samco ELSS Tax Save...	3.39
UTI Healthcare Fund...	2.83
UTI Small Cap Fund-Reg(G)	2.05
Union Active Moment...	1.68
ITI Pharma & Health...	1.60

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

CAPLIN POINT LABORATORIES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES